Antidepressant drugs and risk of developing glioma: a national registry-based case-control study and a meta-analysis
American Journal of Epidemiology · 2024
DOI: 10.1093/aje/kwae100 ↗Kurz gefasst
Metaanalyse in der Zeitschrift American Journal of Epidemiology, 2024. Verfasst von Charlotte Malmberg und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Neurosciences, Umeå University, S-901 85 Umeå, Sweden. Hauptthemen laut MEDLINE: Antidepressive Agents, Brain Neoplasms, Glioma, Registries. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Regional Cancer Centre of Northern Sweden, Swedish Cancer Foundation, Umeå University hospital.
Abstract (Originalsprache)
Whether use of antidepressants is related to the risk of developing lower-grade (WHO grades 2-3) and higher-grade (WHO grade 4) glioma was investigated in this study. A registry-based case–control study was performed with 1283 glioma case patients and 6400 age-, sex-, and geographically matched control participants who were diagnosed in Sweden during 2009-2013. Conditional logistic regression was used to analyze whether selective serotonin reuptake inhibitors (SSRIs) or non-SSRIs were associated with the risk of developing lower- or higher-grade glioma in the study population. Our results show that use of antidepressant medication was not associated with the risk of developing glioma. We also performed a meta-analysis in which the data set from the present study was combined with results from 2 previous epidemiologic studies to answer the same questions. The meta-analysis showed a modest risk reduction of developing glioma in relation to antidepressant treatment (odds ratio = 0.90; 95% CI, 0.83-0.97) when all glioma subgroups and all forms of antidepressant medications were combined. In conclusion, it remains possible that antidepressants may have common monoaminergic mechanism(s) that reduce the risk of developing glioma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences, Neurosciences, Umeå University, S-901 85 Umeå, Sweden.
- Department of Radiation Sciences, Oncology, Umeå University, S-901 87 Umeå, Sweden.
- Department of Chemistry, Umeå University, S-901 87 Umeå, Sweden.
ORCID-Profile: Barbro Numan Hellquist, Maria Sandström, Wendy Yi-Ying Wu, Benny Björkblom, Beatrice Melin, Rickard L Sjöberg
Förderung
- Regional Cancer Centre of Northern Sweden
- Swedish Cancer Foundation
- Umeå University hospital
Zitieren
APA
Malmberg, C., Hellquist, B. N., Sadanandan, S. A., Sandström, M., Wu, W. Y., Björkblom, B., Melin, B., & Sjöberg, R. L. (2024). Antidepressant drugs and risk of developing glioma: a national registry-based case-control study and a meta-analysis. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwae100
Vancouver
Malmberg C, Hellquist BN, Sadanandan SA, Sandström M, Wu WY, Björkblom B, et al. Antidepressant drugs and risk of developing glioma: a national registry-based case-control study and a meta-analysis. American Journal of Epidemiology. 2024. doi:10.1093/aje/kwae100
BibTeX
@article{Malmberg2024,
author = {Malmberg, Charlotte and Hellquist, Barbro Numan and Sadanandan, Sajna Anand and Sandström, Maria and Wu, Wendy Yi-Ying and Björkblom, Benny and Melin, Beatrice and Sjöberg, Rickard L},
title = {Antidepressant drugs and risk of developing glioma: a national registry-based case-control study and a meta-analysis},
journal = {American Journal of Epidemiology},
year = {2024},
doi = {10.1093/aje/kwae100}
}
EUVIMED